North America Cancer Therapies Market Size By Therapy Type (Chemotherapy, Targeted Therapy), By Cancer Type (Blood Cancer, Solid Tumors), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By End-User (Hospitals, Cancer Specialty Clinics), Size and Forecast
Report ID: 467918|No. of Pages: 202
North America Cancer Therapies Market Size By Therapy Type (Chemotherapy, Targeted Therapy), By Cancer Type (Blood Cancer, Solid Tumors), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By End-User (Hospitals, Cancer Specialty Clinics), Size and Forecast
North America Cancer Therapies Market Size and Forecast
North America Cancer Therapies Market size was valued at USD 3.90 Billion in 2024 and is projected to reach USD 7.43 Billion by 2031, growing at a CAGR of 8.4% from 2024 to 2031.
- Cancer therapies encompass a range of medical treatments designed to eradicate or control cancerous cells. These therapies are tailored to the specific type and stage of cancer, as well as the patient’s overall health.
- Various therapies are employed to combat cancer, including surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy.
- Surgery is often used to remove cancerous tumors, while chemotherapy involves the use of drugs to kill cancer cells. Radiation therapy utilizes high-energy rays to destroy cancer cells.
- Immunotherapy harnesses the body’s immune system to fight cancer, and targeted therapy focuses on specific molecules involved in cancer growth.
- The choice of therapy depends on factors such as the type and stage of cancer, the patient’s overall health, and individual preferences.
- Ongoing research and innovation are driving the development of new and more effective cancer therapies. Scientists are exploring emerging approaches like CAR-T cell therapy and gene therapy, which hold promise for personalized and targeted treatments.
North America Cancer Therapies Market Dynamics
The key market dynamics that are shaping the North America cancer therapies market include:
Key Market Drivers
- Increasing Cancer Prevalence: Rising incidence rates, particularly among aging populations, create unprecedented demand for advanced cancer therapies?. The National Cancer Institute reported 1.9 million new cancer cases in the United States in 2023, driving substantial market expansion.
- Technological Advancements in Precision Medicine: Advanced diagnostic tools are facilitating early detection and intervention strategies. For instance, in October 2023, Merck announced breakthrough in targeted immunotherapy, demonstrating significant market potential.
- Substantial Government and Private Research Funding: Collaborative research initiatives between academic institutions and pharmaceutical companies are expanding. Public-private partnerships are driving innovative therapeutic solutions. Strategic investments are fundamentally reshaping cancer treatment landscapes. ?.?
- Growing Healthcare Infrastructure and Accessibility: Expanded insurance coverage is facilitating broader access to advanced therapies?. The Centers for Disease Control reported improved cancer screening rates of 67.5% in 2023, indicating enhanced healthcare infrastructure.
Key Challenges:
- Hindering High Cost of Treatment: One of the most significant challenges facing the North American cancer therapies market is the exorbitant cost of treatments, particularly for novel therapies like immunotherapy and targeted therapy. These treatments can be prohibitively expensive, making them inaccessible to many patients, especially those without adequate insurance coverage.
- Hampering Intellectual Property Challenges: The development of new cancer therapies is a complex and costly process, often involving significant research and development investments. Protecting intellectual property rights is crucial for pharmaceutical companies to recoup their investments and continue innovating.
- Challenging Regulatory Hurdles: The regulatory approval process for new cancer therapies is rigorous and time-consuming. Obtaining regulatory approval from agencies like the FDA involves extensive clinical trials to demonstrate safety and efficacy.
- Obstructing Healthcare Disparities: Access to cancer care can vary significantly across different demographic groups in North America. Disparities in healthcare access, insurance coverage, and socioeconomic status can limit the availability of advanced cancer therapies to certain populations.
Key Trends
- Emerging Immunotherapy and Targeted Therapies: Targeted therapies are demonstrating improved patient outcomes and reduced side effects. Personalized treatment strategies are becoming increasingly sophisticated. Biotechnology firms are investing heavily in groundbreaking therapeutic methodologies?.
- Rising Healthcare Expenditure and Insurance Coverage: The American Cancer Society noted healthcare spending on cancer treatments reached $208.9 billion in 2023. Comprehensive insurance policies are increasingly covering advanced therapeutic interventions. Complex treatment modalities are becoming more financially accessible.
- Aging Population and Demographic Shifts: The U.S. Census Bureau projected 73 million Americans aged 65+ by 2030, significantly impacting cancer therapy markets. Age-related cancer risks are driving demand for sophisticated treatment solutions. Demographic transitions are creating substantial market opportunities?.
- Regulatory Support and Accelerated Approval Processes: The FDA approved 12 novel cancer therapies in 2023, indicating supportive regulatory environments. Expedited review processes are facilitating faster market entry for innovative treatments. Regulatory frameworks are becoming more adaptive and patient-centric.
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
What's inside a VMR
industry report?
>>> Ask For Discount @ – https://www.verifiedmarketresearch.com/ask-for-discount/?rid=467918
North America Cancer Therapies Market Regional Analysis
Here is a more detailed regional analysis of the North America cancer therapies market:
- The North America Cancer Therapies Market is experiencing robust growth driven by the advancements in treatment modalities and rising cancer prevalence coupled with the adoption of personalized medicine and immunotherapy.
- The American Association of Cancer Research projects nearly 2.3 million cancer diagnoses annually in the U.S. by 2040, underscoring the demand for innovative treatments.
- The approval of therapies like Genentech’s Columvi for diffuse B-cell lymphoma in June 2023 reflects the accelerated pipeline for advanced cancer drugs?
- Personalized treatments, utilizing genomic sequencing and biomarker analysis, are now used by 60% of oncologists in the region, improving treatment precision and efficacy.
- Similarly, immunotherapy innovations, such as CAR-T cell therapies, are transforming care for hard-to-treat cancers. These approaches reflect a paradigm shift toward tailored and immune-based therapies, increasing their integration into oncology practices.
- Digital health technologies and outpatient care models are further enhancing market dynamics. Tools like telemedicine and AI-powered diagnostics are improving access to cancer care and optimizing treatment outcomes.
- The outpatient care facilities are providing more flexible, cost-effective treatment options, aligning with patient needs for convenience and comprehensive support?.
- Collaborative initiatives and data-sharing efforts are also driving the innovation, with consortia and public-private partnerships advancing research.
- Open-access databases for genomics and clinical trials foster collaboration, accelerating the development and approval of novel therapies to meet the region’s growing cancer care demands?.
North America Cancer Therapies Market: Segmentation Analysis
The North America Cancer Therapies Market is segmented based on By Therapy Type, By Cancer Type, By Distribution Channel, By End-User.
North America Cancer Therapies Market, By Therapy Type
- Chemotherapy
- Targeted Therapy
- Immunotherapy
- Hormonal Therapy
- Other Therapies
Based on Therapy Type, the North America Cancer Therapies Market is bifurcated into Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Others. The targeted therapy segment is dominating the North America cancer therapies market, due to its effectiveness in specifically attacking cancer cells while minimizing damage to healthy cells. However, the immunotherapy segment is experiencing rapid growth, owing to the rising adoption of immune checkpoint inhibitors, CAR-T cell therapies, and cancer vaccines.
North America Cancer Therapies Market, By Cancer Type
1. Blood Cancer
- Leukemia
- Lymphoma
- Myeloma
2. Solid Tumors
- Breast
- Lung
- Prostate
- Colorectal
- Other Solid Tumors
Based on Cancer Type, the North America Cancer Therapies Market is bifurcated into Blood Cancer, Solid Tumors. The solid tumors segment is dominating the North America cancer therapies market, due to their high incidence and advanced treatment developments. However, the blood cancer segment is experiencing rapid growth. Advances in CAR-T cell therapy and immune checkpoint inhibitors are driving substantial interest in this area.
North America Cancer Therapies Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Specialty Pharmacies
- Others
Based on Distribution Channel, the North America Cancer Therapies Market is bifurcated into Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, Others. The hospital pharmacies segment is dominating the North America cancer therapies market, driven by the high frequency of prescriptions for oncology treatments in hospital settings, where specialized facilities and expert care are more accessible. However, the specialty pharmacies segment is experiencing rapid growth. These pharmacies cater specifically to high-cost, complex cancer therapies, including targeted drugs and immunotherapies that require special handling, administration, and patient education.
North America Cancer Therapies Market, By End-User
- Hospitals
- Cancer Specialty Clinics
- Academic Research Institutions
- Others
Based on End-User, the North America Cancer Therapies Market is bifurcated into Hospitals, Cancer Specialty Clinics, Academic Research Institutions, Others. The hospitals segment is dominating the North America cancer therapies market, including advanced diagnostic tools, specialized treatments, and access to state-of-the-art therapies. However, the cancer specialty clinics segment is experiencing rapid growth. As cancer care is becoming more specialized, patients are increasingly turning to these clinics for targeted treatments and personalized care.
Key Players
The “North America Cancer Therapies Market” study report will provide valuable insight with an emphasis on the North America market. The major players in the market are include Johnson and Johnson, AstraZeneca PLC, Merck & Co. Inc., Bayer AG, Amgen Inc, F. Hoffmann-La Roche Ltd, Eli Lilly and Company, Novartis AG, Pfizer Inc, Bristol Myers Squibb Company, among others.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players.
North America Cancer Therapies Market Key Developments
- In September 2022, Eli Lilly and Company announced that the FDA has approved Retevmo (selpercatinib) in 40 mg and 80 mg capsule formulations for treating adult patients with locally advanced or metastatic solid tumors. This approval applies to cases where tumors have a RET gene fusion, have progressed after prior systemic treatments, or lack satisfactory alternative options.
- In January 2023, Zimmer Biomet has acquired Embody Inc., a company specializing in soft tissue healing solutions. This acquisition will enhance Zimmer Biomet’s capabilities in the Cancer Therapies field.
Report Scope
| Report Attributes | Details |
|---|---|
| Study Period | 2021-2031 |
| Base Year | 2024 |
| Forecast Period | 2024-2031 |
| Historical Period | 2021-2023 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Johnson and Johnson, AstraZeneca PLC, Merck & Co. Inc., Bayer AG, Amgen Inc, F. Hoffmann-La Roche Ltd, Eli Lilly and Company, Novartis AG, Pfizer Inc, Bristol Myers Squibb Company, among others. |
| Segments Covered | By Therapy Type, By Cancer Type, By Distribution Channel, By End-User. |
| Customization scope | Free report customization (equivalent to up to 4 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Research Methodology of Verified Market Research:
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at Verified Market Research.
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.
Frequently Asked Questions
Report Research Methodology
Verified Market Research uses the latest researching tools to offer accurate data insights. Our experts deliver the best research reports that have revenue generating recommendations. Analysts carry out extensive research using both top-down and bottom up methods. This helps in exploring the market from different dimensions.
This additionally supports the market researchers in segmenting different segments of the market for analysing them individually.
We appoint data triangulation strategies to explore different areas of the market. This way, we ensure that all our clients get reliable insights associated with the market. Different elements of research methodology appointed by our experts include:
Exploratory data mining
Market is filled with data. All the data is collected in raw format that undergoes a strict filtering system to ensure that only the required data is left behind. The leftover data is properly validated and its authenticity (of source) is checked before using it further. We also collect and mix the data from our previous market research reports.
All the previous reports are stored in our large in-house data repository. Also, the experts gather reliable information from the paid databases.
For understanding the entire market landscape, we need to get details about the past and ongoing trends also. To achieve this, we collect data from different members of the market (distributors and suppliers) along with government websites.
Last piece of the ‘market research’ puzzle is done by going through the data collected from questionnaires, journals and surveys. VMR analysts also give emphasis to different industry dynamics such as market drivers, restraints and monetary trends. As a result, the final set of collected data is a combination of different forms of raw statistics. All of this data is carved into usable information by putting it through authentication procedures and by using best in-class cross-validation techniques.
Data Collection Matrix
| Perspective | Primary Research | Secondary Research |
|---|---|---|
| Supplier side |
|
|
| Demand side |
|
|
Econometrics and data visualization model
Our analysts offer market evaluations and forecasts using the industry-first simulation models. They utilize the BI-enabled dashboard to deliver real-time market statistics. With the help of embedded analytics, the clients can get details associated with brand analysis. They can also use the online reporting software to understand the different key performance indicators.
All the research models are customized to the prerequisites shared by the global clients.
The collected data includes market dynamics, technology landscape, application development and pricing trends. All of this is fed to the research model which then churns out the relevant data for market study.
Our market research experts offer both short-term (econometric models) and long-term analysis (technology market model) of the market in the same report. This way, the clients can achieve all their goals along with jumping on the emerging opportunities. Technological advancements, new product launches and money flow of the market is compared in different cases to showcase their impacts over the forecasted period.
Analysts use correlation, regression and time series analysis to deliver reliable business insights. Our experienced team of professionals diffuse the technology landscape, regulatory frameworks, economic outlook and business principles to share the details of external factors on the market under investigation.
Different demographics are analyzed individually to give appropriate details about the market. After this, all the region-wise data is joined together to serve the clients with glo-cal perspective. We ensure that all the data is accurate and all the actionable recommendations can be achieved in record time. We work with our clients in every step of the work, from exploring the market to implementing business plans. We largely focus on the following parameters for forecasting about the market under lens:
- Market drivers and restraints, along with their current and expected impact
- Raw material scenario and supply v/s price trends
- Regulatory scenario and expected developments
- Current capacity and expected capacity additions up to 2027
We assign different weights to the above parameters. This way, we are empowered to quantify their impact on the market’s momentum. Further, it helps us in delivering the evidence related to market growth rates.
Primary validation
The last step of the report making revolves around forecasting of the market. Exhaustive interviews of the industry experts and decision makers of the esteemed organizations are taken to validate the findings of our experts.
The assumptions that are made to obtain the statistics and data elements are cross-checked by interviewing managers over F2F discussions as well as over phone calls.
Different members of the market’s value chain such as suppliers, distributors, vendors and end consumers are also approached to deliver an unbiased market picture. All the interviews are conducted across the globe. There is no language barrier due to our experienced and multi-lingual team of professionals. Interviews have the capability to offer critical insights about the market. Current business scenarios and future market expectations escalate the quality of our five-star rated market research reports. Our highly trained team use the primary research with Key Industry Participants (KIPs) for validating the market forecasts:
- Established market players
- Raw data suppliers
- Network participants such as distributors
- End consumers
The aims of doing primary research are:
- Verifying the collected data in terms of accuracy and reliability.
- To understand the ongoing market trends and to foresee the future market growth patterns.
Industry Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|---|---|
|
|
